Melbourne ranked world’s most liveable city for sixth consecutive year by EIU
Melbourne is the world’s most liveable city for a sixth consecutive year, according to the Economist Intelligence Unit (EIU).The EIU index scores 140 of the world’s major cities in healthcare, education, stability, culture, environment and infrastructure. Melbourne scored…
Nature 2016 Research Translation and Innovation Symposium (August 2016)
August 2016 Leadership | Culture | Communication | Collaboration | Human Capital | Scale These were the strong themes emerging from the Nature 2016 Research Translation and Innovation Symposium held in Canberra last week on Thursday 11th of…
Study shines new light on programmed cell death
12th August, 2016 A form of regulated cell death known as necroptosis – and its role in health and disease – is the topic of new research by Walter and Eliza Hall Institute scientists. An international team of…
Medtech Trade Mission Going Ahead – Limited Places Still Available!
BioMelbourne Network, on behalf of the State Government of Victoria, is leading a major Medtech Mission to the United States including AdvaMed 2016 – the largest annual medical technology conference on the US calendar. There are still limited…
BioMelbourne Network Members Invited to Meet with International Medtronic Diabetes Representative
US based Medtronic representative, Dr Huzefa Neemuchwala, will be in Melbourne this month. BioMelbourne Network member organisations are invited to meet with Dr Neemuchwala. Interested organisations, please contact Dr Krystal Evans on 9667 6161 Dr Huzefa Neemuchwala, PhD MBA,…
FULLY BOOKED – Free Seminar with Dr Gerald Chan – The Role of Universities in the Innovation Ecosystem
THIS SEMINAR IS FULLY BOOKED The BioMelbourne Network and Biomedical Research Victoria present international guest speaker, Dr Gerald Chan, CEO, Morningside, USA Free Seminar: The Role of Universities in the Innovation Ecosystem With Australia’s changing economy, the role of universities…
Opthea Reports Positive Data from wet AMD Clinical Trial
26th July, 2016 Melbourne, Australia, July 26 2016 – Opthea Limited (ASX:OPT) • Phase 1 dose escalation study met primary objective demonstrating OPT-302 safety and tolerability as monotherapy and in combination with standard of care Lucentis® • Changes…
Stem cells healing broken hearts; Making cancer treatment less aggressive, more effective
The National Stem Cell Foundation of Australia (based in Victoria) supports stem cell science and educates the community about the potential and dangers of stem cell therapies.The winners of the 2016 Metcalf Prizes for Stem Cell Research were…
Launch of Medical Technology and Pharmaceuticals Growth Centre
26th July, 2016 MTP Connect chief executive officer Sue MacLeman says her Federal Government funded initiative aim is “to drive competitiveness and productivity of the sector”. Ms MacLeman told Biotech Daily that the launch of a 10-year plan…
Breakthrough lung cancer drug discovery by Melbourne researchers
26th July, 2016 A BREAKTHROUGH discovery has opened up a potential new drug to stop lung cancer and emphysema as well as detecting the killer diseases much sooner. Researchers from Melbourne’s Hudson Institute of Medical Science have identified…
Monash part of world-first clinical trial for lymphoma patients
26th July, 2016 A novel therapy for aggressive lymphoma is being tested in a world-first clinical trial at the Monash Health Translation Precinct (MHTP).In early 2015, researchers at Monash University and Peter MacCallum Cancer Centre showed the novel…
Animation library to increase science literacy in Victoria
26th July, 2016 The Walter and Eliza Hall Institute of Medical Research will embark on an exciting new project to create a free online database of more than 100 scientifically accurate 3D biomedical animations.Addressing a strong demand within…
